Skip to content
HomeLatest newsJohnson & Johnson makes Interbrand’s 100 Best Global Brands 2016 list
Michael Sneed
Michael Sneed, Worldwide Vice President, Global Corporate Affairs, and Chief Communication Officer for Johnson & Johnson

Johnson & Johnson makes Interbrand’s 100 Best Global Brands 2016 list

This year, Johnson & Johnson joins companies like IBM and Facebook in being named one of Interbrand’s top brands. Here’s what it takes to nab a spot on the list.

Michael Sneed, Worldwide Vice President, Global Corporate Affairs, and Chief Communication Officer for Johnson & Johnson

The best companies in the world know the importance of consistently putting innovation front and center—companies like Johnson & Johnson, which has been focused on growing and evolving as a brand for the past 130 years.

Thanks to this dedication to innovation, brand management consultancy Interbrand has just named Johnson & Johnson to its 100 Best Global Brands 2016 list.

As Interbrand explained in its announcement, in order to “understand the real drivers of growth for…your business, you need to understand people.”

And that’s something Johnson & Johnson has firmly believed in since its inception: The company Credo states that its first responsibility is to the healthcare professionals, parents and others who use its products.

“Our passion is building a healthier future for people around the world,” notes Michael Sneed, Worldwide Vice President, Global Corporate Affairs, and Chief Communication Officer. “We use the power of our brand to advance causes we believe in.”

Check out this video with Sneed to learn more about how Johnson & Johnson strives to continuously innovate and bolster its corporate brand—and, more importantly, the well-being of people around the world.

hqdefault.jpg
Johnson & Johnson Named One of 2016’s Best Global Brands

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.